PTGDR and Stroke: While DP1 agonists seem to alleviate brain damage upon stroke (Ahmad et al., 2010), DP1 antagonists are being proposed to treat disorders such as ALS (de Boer et al., 2014) and Krabbe disease (Mohri et al., 2006).